Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention

Over the past decade, there have been significant developments in treatment for ovarian cancer, yet the lack of targeted therapy with few side effects still represents a major issue. The cytochrome P450 (CYP) enzyme family plays a vital role in the tumorigenesis process and metabolism of drugs and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-saraireh, Yousef M., Alshammari, Fatemah O. F. O., Abu-azzam, Omar H., Al-dalain, Sa’ed M., Al-sarayra, Yahya M., Haddad, Mansour, Makeen, Hafiz, Al-Qtaitat, Aiman, Almermesh, Mohammad, Al-sarayreh, Sameeh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669316/
https://www.ncbi.nlm.nih.gov/pubmed/38001897
http://dx.doi.org/10.3390/biomedicines11112898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669316/
https://www.ncbi.nlm.nih.gov/pubmed/38001897
http://dx.doi.org/10.3390/biomedicines11112898

Ejemplares similares